跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CUBICIN RF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CUBICIN RF
Authorized
STANDARD
CUBICIN RF
CUBIST PHARMACEUTICALS LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4485c155f9d09eb6
Company
CUBIST PHARMACEUTICALS LLC
Type
Standard
Approval Details
Approval Id
4485c155f9d09eb6
Drug Approval Canada Name
CUBICIN RF
Product Name
CUBICIN RF
Status
Marketed
Status Date
2018-01-17
Original Market Date
2018-01-17
Din
02465493
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.28.12
Atc Original
J01XX09 DAPTOMYCIN
Atc Name
j 01 xx 09
Aig Number
0152298001
Company Name
CUBIST PHARMACEUTICALS LLC
Company Address
Tribschenstrasse 60, 6005 Luzern, Luzern, Switzerland, 6005
Company Detail Path
/organization/cubist-pharmaceuticals-llc
Company Information
Pharmaceutical Company Name
CUBIST PHARMACEUTICALS LLC
Country Name
United States
Province Name
Massachusetts
City Name
马萨诸塞州米德尔塞克斯县
Address
65 Hayden Ave
Website
http://www.cubist.com
Active Ingredients
DAPTOMYCIN
500 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4485c155f9d09eb6
Type
Standard
Back to Health Canada Approvals